A Single-Gene Cause in 29.5% of Cases of Steroid-Resistant Nephrotic Syndrome
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Steroid-resistant nephrotic syndrome (SRNS) is the second most frequent cause of ESRD in the first two decades of life. Effective treatment is lacking. First insights into disease mechanisms came from identification of single-gene causes of SRNS. However, the frequency of single-gene causation and its age distribution in large cohorts are unknown. We performed exon sequencing of NPHS2 and WT1 for 1783 unrelated, international families with SRNS. We then examined all patients by microfluidic multiplex PCR and next-generation sequencing for all 27 genes known to cause SRNS if mutated. We detected a single-gene cause in 29.5% (526 of 1783) of families with SRNS that manifested before 25 years of age. The fraction of families in whom a single-gene cause was identified inversely correlated with age of onset. Within clinically relevant age groups, the fraction of families with detection of the single-gene cause was as follows: onset in the first 3 months of life (69.4%), between 4 and 12 months old (49.7%), between 1 and 6 years old (25.3%), between 7 and 12 years old (17.8%), and between 13 and 18 years old (10.8%). For PLCE1, specific mutations correlated with age of onset. Notably, 1% of individuals carried mutations in genes that function within the coenzyme Q10 biosynthesis pathway, suggesting that SRNS may be treatable in these individuals. Our study results should facilitate molecular genetic diagnostics of SRNS, etiologic classification for therapeutic studies, generation of genotype-phenotype correlations, and the identification of individuals in whom a targeted treatment for SRNS may be available.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“among these were many gene products currently known to be associated with hereditary nephrotic syndrome (Sadowski et al., 2015).”
From A Multi-layered Quantitative In Vivo Expression Atlas of the Podocyte Unravels Kidney Disease Candidate Genes (2018) · cites this paper as Sadowski et al., 2015
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Boute, N., Gribouval, O., Roselli, S., Benessy, F., Lee, H., Fuchshuber, A., Dahan, K., Gubler, M.-C., Niaudet, P., & Antignac, C. (2000) · Nature Genetics · doi:10.1038/74166 · Cited by 1,444
The spectrum of podocytopathies: A unifying view of glomerular diseases
Wiggins, R.-C. (2007) · Kidney International · doi:10.1038/sj.ki.5002222 · Cited by 757
Hinkes, B., Wiggins, R. C., Gbadegesin, R., Vlangos, C. N., Seelow, D., Nürnberg, G., Garg, P., Verma, R., Chaib, H., Hoskins, B. E., et al. (2006) · Nature Genetics · doi:10.1038/ng1918 · Cited by 569
Self-citationSmith, J. M., Stablein, D. M., Munoz, R., Hebert, D., & McDonald, R. A. (2007) · Pediatric Transplantation · doi:10.1111/j.1399-3046.2007.00704.x · Cited by 479
Hinkes, B. G., Mucha, B., Vlangos, C. N., Gbadegesin, R., Liu, J., Hasselbacher, K., Hangan, D., Ozaltin, F., Zenker, M., Hildebrandt, F., et al. (2007) · Pediatrics · doi:10.1542/peds.2006-2164 · Cited by 444
Self-citationRuf, R. G., Lichtenberger, A., Karle, S. M., Haas, J. P., Anacleto, F. E., Schultheiss, M., Zalewski, I., Imm, A., Ruf, E.-M., Mucha, B., et al. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000113552.59155.72 · Cited by 417
Self-citationCOQ6 mutations in human patients produce nephrotic syndrome with sensorineural deafness
Heeringa, S. F., Chernin, G., Chaki, M., Zhou, W., Sloan, A. J., Ji, Z., Xie, L. X., Salviati, L., Hurd, T. W., Vega-Warner, V., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45693 · Cited by 398
Self-citationWeber, S., Gribouval, O., Esquivel, E. L., Morinière, V., Tête, M.-J., Legendre, C., Niaudet, P., & Antignac, C. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00776.x · Cited by 375
ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption
Ashraf, S., Gee, H. Y., Woerner, S., Xie, L. X., Vega-Warner, V., Lovric, S., Fang, H., Song, X., Cattran, D. C., Avila-Casado, C., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci69000 · Cited by 341
Self-citationGetting a foothold in nephrotic syndrome
Somlo, S., & Mundel, P. (2000) · Nature Genetics · doi:10.1038/74139 · Cited by 271
Cited by
Items 601–651 of 651
Magliulo, S., Genovesi, M. L., Lucchetti, L., Orlando, V., Novelli, A., Massella, L., & Terracciano, A. (2025) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2025.105029
Lu, H., Sun, J., & Sun, J. (2025) · Renal Failure · doi:10.1080/0886022x.2025.2573857
“Specifically, while MCd typically carries a favorable prognosis, 10–15% of adult patients develop steroid-resistant diseases, increasing their risk of progression to ESRd [6]. in contrast, FSGS is more aggressive, and 40–60% of patients may progress to ESRd within 10 years after diagnosis [7].”
Gcobo, T., Katsukunya, J. N., Lamola, L., Awany, D., Ndadza, A., Dandara, C., & Mnika, K. (2025) · Genes · doi:10.3390/genes16111295
“4;c.1A>T, previously reported as a founder mutation in the Egyptian population [34], was found in 57.1% patients with NS related to NPHS2 and was implicated in two sibling cases with CNS, a phenotype of NS characterised by nephrotic-range proteinuria and oedema within the first three months after…”
InfluentialElaraby, N. M., Metwally, A. M., Sayed, S. M., Ashaat, N. A., Gamal, M., Farouk, D., Abuelela, S. A., Ramadan, A., Kobesiy, M. M., Shaker, M. M., et al. (2025) · Molecular and Cellular Pediatrics · doi:10.1186/s40348-025-00203-2
Lin, L., Ye, Y., Fu, H., Gu, W., Zhao, M., Sun, J., Cao, Z., Huang, G., Xie, Y., Liu, F., et al. (2024) · Figshare · doi:10.6084/m9.figshare.24558225
Lin, L., Ye, Y., Fu, H., Gu, W., Zhao, M., Sun, J., Cao, Z., Huang, G., Xie, Y., Liu, F., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26639304
Additional file 1 of In vivo characterization of a podocyte-expressed short podocin isoform
Butt, L., Unnersjö‐Jess, D., Reilly, D., Hahnfeldt, R., Rinschen, M. M., Bozek, K., Schermer, B., Benzing, T., & Höhne, M. W. (2024) · Figshare · doi:10.6084/m9.figshare.26656408
Lin, L., Ye, Y., Fu, H., Gu, W., Zhao, M., Sun, J., Cao, Z., Huang, G., Xie, Y., Liu, F., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26639316
Tanzi, A., Buono, L., Grange, C., Iampietro, C., Brossa, A., Arcolino, F. O., Arigoni, M., Calogero, R., Perin, L., Deaglio, S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26698357
Lin, L., Ye, Y., Fu, H., Gu, W., Zhao, M., Sun, J., Cao, Z., Huang, G., Xie, Y., Liu, F., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24558113
Cheng, X., Chen, J., Yang, X., Chan, H., Yang, X., Jiao, J., Wang, A., Zhang, G., Chen, X., Li, X., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25678487
Tanzi, A., Buono, L., Grange, C., Iampietro, C., Brossa, A., Arcolino, F. O., Arigoni, M., Calogero, R., Perin, L., Deaglio, S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26697297
Lin, L., Ye, Y., Fu, H., Gu, W., Zhao, M., Sun, J., Cao, Z., Huang, G., Xie, Y., Liu, F., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26639301
Wongboonsin, J., Gibson, K. M., Ke, J., Sentell, Z. T., Arcila-Galvis, J. E., Koyama, S., Greenberg, A., Reynolds, K. M., Montini, G., Magistroni, R., et al. (2025) · Kidney International · doi:10.1016/j.kint.2025.12.013
Self-citationGenç, E. E., Karakaya, D., Kenan, B. U., Soylu, A. G., Savaş, I. K., & Çakıcı, E. K. (2025) · Indian Journal of Nephrology · doi:10.25259/ijn_753_2025
Lang, S. H., Cottingham, N., Donnelly, C. M., Risen, S., Malatesta-Muncher, R., Brewer, E. D., Saland, J., Benchimol, C., Scaglia, F., & Ganesh, J. (2026) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2026.109731
Identification of monogenic variants in steroid-resistant and steroid-sensitive nephrotic syndrome
Mansour, B., Lemberg, K., Schneider, R., Saida, K., Elmubarak, I., Yu, S., Yousef, K., Nicolas, C., Riedhammer, K. M., Zahoor, M. Y., et al. (2026) · Pediatric Nephrology · doi:10.1007/s00467-026-07151-7
Self-citationWang, C., Yin, G., Zhou, Y., Song, Y.-C., Tian, M.-L., Wang, X.-Y., Wang, J., Li, Q., Zang, R., Yang, Z.-L., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-38189-0
“The intermediate PRS distribution in SRNS further suggests that common polygenic factors contribute to disease pathogenesis beyond the established role of monogenic mutations 4 .”
A Simple Tool to Predict Genetic Focal Segmental GlomerulosclerosisPreprint
Xie, J., Hao, X. Q., Liu, Z., Yu, S., Zhao, Y., Fang, Z., Liu, J., Zhang, C., Ma, J., Zheng, Q., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-8630004/v1
Hermle, T. F., Lang, K., & Milosavljevic, J. (2026) · Medizinische Genetik · doi:10.1515/medgen-2025-2037
“While NPHS1 and NPHS2 are the most prevalent causative genes in congenital nephrotic syndrome, other genes that account for a significant proportion of the remaining cases include WT1 , LAMB2 , and PLCE1 [14], which will be discussed below.”
Pellegrino, G., & Strippoli, G. F. M. (2026) · Pediatric Nephrology · doi:10.1007/s00467-026-07223-8 · Cited by 1
“…for example, ML-based analyses have been used to identify genotype–phenotype correlations and predict response to immunosuppressive therapy, distinguishing children with monogenic disease, who are unlikely to benefit from intensified immunosuppression, from those with immune-mediated forms [41].”
Weber, S. (2025) · Elsevier eBooks · doi:10.1016/b978-3-437-21447-9.50177-x
Hoxha, E. (2026) · Die Innere Medizin · doi:10.1007/s00108-026-02102-8
Protéinuries génétiques causées par déficit de réabsorption tubulaire proximale
Bedin, M. (2019) · theses.fr (ABES) · doi:10.70675/a3dc7a92z6158z43fez9b6bzb9ad00e7acbf
Population Modeling Defines Adult-Onset FSGS Caused by NPHS2 Pathogenic Variants
Ding, W. Y., Malone, K. E., Clark, D. M., Komers, R., Tory, K., Harrison, P., Erlandsson, F., & Saleem, M. A. (2026) · Kidney International Reports · doi:10.1016/j.ekir.2026.106533
Batool, L., Hariharan, K., Stölting, G., Zhong, T., Tsvetkov, D., Gossen, M., & Kurtz, A. (2026) · Cells · doi:10.3390/cells15080712
“Human genetic studies have identified at least 27 genes involved in dominant or recessive forms of FSGS [8].”
Gan, Y., Yang, X., Chan, H., Yang, S., Yang, H., & Li, Q. (2026) · Journal of Medical Genetics · doi:10.1136/jmg-2025-111444
Bravo, W. C. (2026) · Pediatrics in Review · doi:10.1542/pir.2025-006891
Adult-Onset Focal Segmental Glomerulosclerosis Associated with CRB2 Gene Variants, a Case Report
Elraggal, M., Zyada, R. S., & Gawish, R. I. (2026) · Central Asian Journal of Nephrology · doi:10.63946/cajn/18719
“For example, Sadowski et al (18) identified monogenic causes in 21.4% of cases with an onset between 19–25 years.”
InfluentialAhmed, L. I., Mohammed, D. A., & Sharif, D. A. (2026) · Molecular Genetics and Metabolism Reports · doi:10.1016/j.ymgmr.2026.101330
Genetic Nephrotic Syndrome in Children and Adolescents: An Update
Varner, J. D., Lane, B. M., & Gbadegesin, R. (2026) · Advances in Kidney Disease and Health · doi:10.1053/j.akdh.2026.03.006
Alqattan, F. F., Azzam, A., Alkanani, H., Alharthi, W., Bahbah, H., Hammed, A., Almaghrabi, M., & Alshami, A. (2026) · Pediatric Nephrology · doi:10.1007/s00467-026-07430-3
“An analysis by Sadowski et al. showed a near-linear relationship between institutional consanguinity rates and the yield of monogenic testing, with a 45.2% monogenic detection rate at a Saudi Arabian centre (71.4% consanguinity) versus 14.3% in a Michigan centre with no consanguineous families [25].”
InfluentialHejenkowska, E. D., Kruszka, P. S., & Swiatecka‐Urban, A. (2026) · Pediatric Nephrology · doi:10.1007/s00467-026-07407-2
“Using targeted exon sequencing, Sadowski et al. identified a single-gene cause in 69.4% of families with CNS and approximately 49.7% of those with iNS, compared to 29.5% overall in a broad SRNS cohort [115].”
InfluentialGreisch, A., Hennaut, E., & Ismaïli, K. (2026) · Cureus · doi:10.7759/cureus.111908
“Recent advances in molecular genetics have led to the identification of pathogenic variants in more than 30 genes involved in podocyte structure and function, the glomerular basement membrane, or ciliary function [3,4].”
New therapeutic hope for rare podocytopathies
Zhang, Y., Wang, F., & Ding, J. (2026) · Pediatric Nephrology · doi:10.1007/s00467-026-07442-z
“Furthermore, the fraction decreased to 25.3% at age of 2 to 6 years, to 17.8% at age of 7 to 12 years, and to about 10.3% at the age of 13 to 18 years [21].”
InfluentialYue, Y., Zhao, F., & Chen, Q. (2026) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.70221
“In contrast, an international cohort study identified only 9 PCOQ10D families among 526 genetically confirmed SRNS cases (Sadowski et al. 2015).”
Genetic mutation patterns in Indonesian children with primary steroid–resistant nephrotic syndrome
Fahlevi, R., Trihono, P. P., Muktiarti, D., Hidayati, E. L., Wahidiyat, P. A., Hafifah, C. N., Nugraha, W. E., & Kasih, M. (2026) · Pediatric Nephrology · doi:10.1007/s00467-026-07327-1
“A greater proportion of subjects with identified SRNS variants in this study were male (6 out of 9), consistent with previous reports indicating a higher prevalence of monogenic SRNS among boys [26, 27].”
Gembillo, G., Casuscelli, C., Spada, A. L., Pietro, Y. D., Cipressa, G., Santoro, D., & Re, C. L. (2026) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2026.2706076
“Pediatric steroid-resistant FSGS carries a substantially higher prevalence of monogenic forms than adult disease [79], different steroid-resistance patterns, and pharmacokinetic data largely extrapolated from adults; the guidance presented here reflects adult evidence only.”
Lim, R. S., 张耀春, Lim, T. S. T., Goh, S. M., Lim, R. S., Ng, J. L., Choo, J., Leow, E. H., Chan, G. C., Chin, H.-L., et al. (2026) · Kidney Medicine · doi:10.1016/j.xkme.2026.101489 · Cited by 1
Hu, L., Zhao, M., & 何庆南 (2026) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-026-05888-4
Dotis, J., & Printza, N. (2026) · Genes · doi:10.3390/genes17091069
Long-term outcomes of childhood nephrotic syndrome
Boyer, O., Sinha, A., Oliva-Dámaso, N., Bomback, A. S., Preka, E., & Bagga, A. (2026) · Kidney International · doi:10.1016/j.kint.2026.06.054
Focal Segmental Glomerulosclerosis Recurrence Post Renal Transplant: A Narrative Review
Thornton, J., Clark, E., & Kant, S. (2026) · Sclerosis · doi:10.3390/sclerosis4040030
“First, the pre-transplant evaluation should revisit the native disease diagnosis and, if not previously performed, incorporate genetic testing, as reclassification as genetic FSGS substantially reduces recurrence risk and may alter donor eligibility [10,26,43].”
Quantitative Proteomics: Recent Advances in Glomerular Disease and Nephrotic Syndrome
Barati, M. T., Cara‐Fuentes, G., Samuelson, D. J., Merchant, M., Rajashekar, G., Gawęda, A. E., Klein, J. B., & Cummins, T. D. (2026) · Glomerular Diseases · doi:10.1159/gdz/acyag003
“Podocyte structure, adhesion to the GBM, and functional role in the filtration barrier are dependent on the ECM and cell cytoskeletal organization [68–70], and mutations in genes of cyto-skeletal elements and regulatory proteins are shown in genetic forms of glomerular diseases [71, 72].”
Fundamentos clínicos y enfoque terapéutico actual del síndrome nefrótico: revisión sistemática
López-Tene, A. P., Bayas-Suárez, D. I., Ocaña-Urquizo, M. A., & Encalada-Bermeo, E. A. (2026) · Sanitas. Revista arbitrada de ciencias de la salud. · doi:10.62574/5n0xmx35
Todorović, P., Kopilaš, A., Racetin, A., Maglica, M., Rizikalo, A., Raguž, F., Kelam, N., & Vukojević, K. (2026) · Life · doi:10.3390/life16101722
“The yield of panel testing in SRNS beyond the first year of life is of the order of 10% to 25% [53,54,56], so most children tested will have no causative variant, and a negative result is not evidence of an immune mechanism.”
InfluentialA Hitchhiker’s Guide to Precision Medicine in Glomerulonephritis
Ramesh, S., Wong, W., Goodall-George, I., Yau, K., & Downie, M. L. (2026) · Canadian Journal of Kidney Health and Disease · doi:10.1177/20543581261497268
A Novel LAMA5 Variant in Adult‐Onset Focal Segmental Glomerulosclerosis: A Case Report
Dahlan, R. A., & Fairoozy, R. H. (2026) · Case Reports in Genetics · doi:10.1155/crig/7603821
“Notably, it is strongly infuenced by the age at disease onset, with monogenic causes identifed in up to 50% of infantile-onset cases, decreasing to approximately 10%–20% in adolescent and adult-onset disease [3].”
InfluentialHu, H., & Huang, Y. (2026) · Genes & Diseases · doi:10.1016/j.gendis.2026.102568
Metadata
- Authors
- Sadowski, C. E., Lovric, S., Ashraf, S., Pabst, W. L., Gee, H. Y., Kohl, S., Engelmann, S., Vega-Warner, V., Fang, H., Halbritter, J., Somers, M. J., Tan, W., Shril, S., Fessi, I., Lifton, R. P., Bockenhauer, D., El-Desoky, S., Kari, J. A., Zenker, M., Kemper, M. J., Mueller, D., Fathy, H. M., Soliman, N. A., & Hildebrandt, F.
- Affiliations
- Boston Children's Hospital (US)
- University of Michigan (US)
- Howard Hughes Medical Institute (US)
- King Abdul Aziz University Hospital (SA)
- Otto-von-Guericke-Universität Magdeburg (DE)
- University Medical Center Hamburg-Eppendorf (DE)
- Stiftung Charité (DE)
- Alexandria University (EG)
- Cairo University (EG)
- Corresponding author
- Sadowski, Carolin E.
- Lovric, Svjetlana
- Ashraf, Shazia
- Pabst, Werner L.
- Gee, Heon Yung
- Kohl, Stefan
- Engelmann, Susanne
- Fang, Humphrey
- Halbritter, Jan
- Somers, Michael J.
- Tan, Weizhen
- Shril, Shirlee
- Fessi, Inès
- Kemper, Markus J.
- Hildebrandt, Friedhelm
- ORCID
- Venue
- Journal of the American Society of Nephrology
- Published
- 2015-06
- Volume
- 26
- Issue
- 6
- Pages
- 1279-1289
- ISSN
- 1046-6673 (ISSN-L)
- PMC
- PMC4446877
- OpenAlex
- W2163605874
- Cited by
- 651
- References
- 41
- Citations by year
- 2026: 45 · 2025: 40 · 2024: 45 · 2023: 63 · 2022: 69 · 2021: 61 · 2020: 55 · 2019: 55 · 2018: 64 · 2017: 62 · 2016: 50 · 2015: 40
- FWCI
- 40.05
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of the American Society of Nephrology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- YUHSpace (Yonsei University Medical Library) (submittedVersion, cc-by-nc-nd)
- Universitätsbibliographie, Universität Duisburg-Essen (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Scholarship@Western (Western University) (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- Nephcure Foundation
- Kidney Research UK (RP45/2008)
- National Institutes of Health
- Manton Center for Orphan Disease Research, Boston Children's Hospital
- National Institute of Diabetes and Digestive and Kidney Diseases (RC4-DK076683, P30DK079310, R01DK076683)
- Topics
- Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
- Health Sciences › Medicine › Oncology › Renal and related cancers
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Keywords
- steroid-resistant nephrotic syndrome, NPHS2, WT1, PLCE1, coenzyme Q10 biosynthesis, age of onset, genotype-phenotype correlation, molecular genetic diagnosis, pediatric kidney disease, end-stage renal disease
- MeSH terms
- Adolescent, Adult, Child, Child, Preschool, Female, Genotype, Heterozygote, Humans, Infant, Male, Membrane Proteins, Middle Aged, Mutation, Nephrotic Syndrome, Pedigree, Phenotype, Retrospective Studies, Cohort Studies, Incidence, Genes, Wilms Tumor, Age of Onset, Risk Assessment, Genetic Predisposition to Disease, Intracellular Signaling Peptides and Proteins, Young Adult, Genetic Association Studies, Real-Time Polymerase Chain Reaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.